Related Experiment Video
Updated: Mar 23, 2026

07:27
Olfactory Assays for Mouse Models of Neurodegenerative Disease
Published on: August 25, 2014
22.7K
Back on the scent: the olfactory system in CNS demyelinating diseases
Albert Joseph1, Gabriele C DeLuca2
1Foundation School Offices, St Mary's Hospital, London, UK.
Journal of Neurology, Neurosurgery, and Psychiatry
|March 23, 2016
Summary
Olfactory dysfunction, or loss of smell, is a common symptom in central nervous system (CNS) demyelinating diseases like multiple sclerosis (MS) and neuromyelitis optica (NMO). This review synthesizes evidence on the anatomical basis and complex pathology of smell loss in these conditions.
Area of Science:
- Neuroscience
- Neurology
- Immunology
Background:
- Olfactory dysfunction is increasingly recognized in various neuropsychiatric conditions.
- Central nervous system (CNS) demyelinating diseases, including multiple sclerosis (MS) and neuromyelitis optica (NMO), are associated with olfactory deficits.
Purpose of the Study:
- To review and synthesize the evidence linking olfactory loss to MS and NMO.
- To explore the anatomical and pathological substrates of olfactory dysfunction in these CNS demyelinating diseases.
Main Methods:
- Review of existing literature on olfactory dysfunction in MS and NMO.
- Analysis of psychophysical, electrophysiological, radiological, and pathological data.
- Synthesis of findings to understand the impact on the olfactory system.
Main Results:
- Olfactory loss is a common clinical feature in multiple sclerosis and neuromyelitis optica.
- The pathology affecting the olfactory system is complex, involving multiple CNS structures.
- Evidence points to specific anatomical substrates underlying olfactory deficits in these diseases.
Conclusions:
- Olfactory dysfunction is a significant, though often overlooked, feature of CNS demyelinating diseases.
- Understanding olfactory system involvement offers novel insights into the pathogenesis of MS and NMO.
- Further research is needed to elucidate the role of the olfactory system in these diseases.
More Related Videos
Related Concept Videos
Olfactory Receptors: Location and Structure
13.9K
The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
13.9K
Olfaction
49.8K
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
The olfactory receptors are embedded in the cilia of the...
49.8K
Physiology of Smell and Olfactory Pathway
13.9K
Humans detect odors with the help of specialized cells located in the upper part of the nasal cavity, called olfactory receptor neurons (ORNs). ORNs possess hair-like structures called cilia, which are receptive to sensations from the inhaled air. When an odorant molecule binds to a specific receptor on the cell of the cilia, it leads to a series of events that ultimately cause the ORN to send electrical signals to the olfactory bulb in the brain through the olfactory nerves.
The olfactory...
The olfactory...
13.9K
Disorders of the Nervous Tissue
3.0K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
3.0K
Nervous Tissue: Myelin
9.6K
The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
9.6K

